Molecular Endocrinology, Vol 6, 1043-1050, Copyright © 1992 by Endocrine Society

ARTICLES

Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast

TA Pham, YP Hwung, D Santiso-Mere, DP McDonnell and BW O'Malley
Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030.

The estrogen receptor (ER) is a transcription factor involved in steroid hormone signal transduction in higher eukaryotes. The receptor also functions as a ligand-dependent transcriptional activator when introduced into Saccharomyces cerevisiae (baker's yeast), which suggests that at least some of the components of the signal transduction pathway are conserved between yeast and mammalian cells, and, moreover, allows the possibility of using this simple eukaryotic organism to dissect receptor function. However, whether the ER actually activates transcription in a mechanistically similar fashion in yeast and mammalian cells is unclear, since it has been reported that the transactivation function within the hormone binding domain (TAF-2) does not function in yeast. In this report, we have characterized the activity of the transactivation functions of the ER in yeast. Our results indicate that both TAF-2 and the N-terminal transactivation region (TAF-1) are functional in yeast and contribute synergistically to the receptor's total activity. These results are consistent with those obtained in mammalian cells. Furthermore, we show that in yeast the antagonistic effects of the antiestrogen nafoxidine arise from a modulation of the synergistic interactions of TAF-1 and TAF-2, and not simply from an inactivation of TAF-2 by antihormone. Finally, we characterize the effect of ER deletion mutants on chromatin structure in yeast. Our data lend support to the view that the formation of competent transcriptional initiation complexes requires a precise disruption of chromatin structure.

This article has been cited by other articles:

				R. Martin, M. B. Taylor, G. Krikun, C. Lockwood, G. E. Akbas, and H. S. Taylor Differential Cell-Specific Modulation of HOXA10 by Estrogen and Specificity Protein 1 Response Elements J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1920 - 1926. [Abstract] [Full Text] [PDF]

				A. Vivacqua, D. Bonofiglio, A. G. Recchia, A. M. Musti, D. Picard, S. Ando, and M. Maggiolini The G Protein-Coupled Receptor GPR30 Mediates the Proliferative Effects Induced by 17{beta}-Estradiol and Hydroxytamoxifen in Endometrial Cancer Cells Mol. Endocrinol., March 1, 2006; 20(3): 631 - 646. [Abstract] [Full Text] [PDF]

				T. Iwasaki, A. Takeshita, W. Miyazaki, W. W. Chin, and N. Koibuchi The Interaction of TR{beta}1-N Terminus with Steroid Receptor Coactivator-1 (SRC-1) Serves a Full Transcriptional Activation Function of SRC-1 Endocrinology, March 1, 2006; 147(3): 1452 - 1457. [Abstract] [Full Text] [PDF]

				A. Warnmark, E. Treuter, A. P. H. Wright, and J.-A. Gustafsson Activation Functions 1 and 2 of Nuclear Receptors: Molecular Strategies for Transcriptional Activation Mol. Endocrinol., October 1, 2003; 17(10): 1901 - 1909. [Abstract] [Full Text] [PDF]

				C. E. Piersen Phytoestrogens in Botanical Dietary Supplements: Implications for Cancer Integr Cancer Ther, June 1, 2003; 2(2): 120 - 138. [Abstract] [PDF]

				J. N. Miner, C. Tyree, J. Hu, E. Berger, K. Marschke, M. Nakane, M. J. Coghlan, D. Clemm, B. Lane, and J. Rosen A Nonsteroidal Glucocorticoid Receptor Antagonist Mol. Endocrinol., January 1, 2003; 17(1): 117 - 127. [Abstract] [Full Text] [PDF]

				C. Pendaries, B. Darblade, P. Rochaix, A. Krust, P. Chambon, K. S. Korach, F. Bayard, and J.-F. Arnal The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice PNAS, February 19, 2002; 99(4): 2205 - 2210. [Abstract] [Full Text] [PDF]

				A. Warnmark, A. Wikstrom, A. P. H. Wright, J.-A. Gustafsson, and T. Hard The N-terminal Regions of Estrogen Receptor alpha and beta Are Unstructured in Vitro and Show Different TBP Binding Properties J. Biol. Chem., November 30, 2001; 276(49): 45939 - 45944. [Abstract] [Full Text] [PDF]

				F. Delaunay, K. Pettersson, M. Tujague, and J.-A. Gustafsson Functional Differences between the Amino-Terminal Domains of Estrogen Receptors alpha and beta Mol. Pharmacol., September 1, 2000; 58(3): 584 - 590. [Abstract] [Full Text]

				P. H. Giangrande, E. A. Kimbrel, D. P. Edwards, and D. P. McDonnell The Opposing Transcriptional Activities of the Two Isoforms of the Human Progesterone Receptor Are Due to Differential Cofactor Binding Mol. Cell. Biol., May 1, 2000; 20(9): 3102 - 3115. [Abstract] [Full Text]

				C.-y. Chang, J. D. Norris, H. Gron, L. A. Paige, P. T. Hamilton, D. J. Kenan, D. Fowlkes, and D. P. McDonnell Dissection of the LXXLL Nuclear Receptor-Coactivator Interaction Motif Using Combinatorial Peptide Libraries: Discovery of Peptide Antagonists of Estrogen Receptors alpha and beta Mol. Cell. Biol., December 1, 1999; 19(12): 8226 - 8239. [Abstract] [Full Text] [PDF]

				M. J. Tetel, P. H. Giangrande, S. A. Leonhardt, D. P. McDonnell, and D. P. Edwards Hormone-Dependent Interaction between the Amino- and Carboxyl-Terminal Domains of Progesterone Receptor in Vitro and in Vivo Mol. Endocrinol., June 1, 1999; 13(6): 910 - 924. [Abstract] [Full Text]

				D. M. Kraichely, J. J. Collins III, R. K. DeLisle, and P. N. MacDonald The Autonomous Transactivation Domain in Helix H3 of the Vitamin D Receptor Is Required For Transactivation and Coactivator Interaction J. Biol. Chem., May 14, 1999; 274(20): 14352 - 14358. [Abstract] [Full Text] [PDF]

				A. Zou, K. B. Marschke, K. E. Arnold, E. M. Berger, P. Fitzgerald, D. E. Mais, and E. A. Allegretto Estrogen Receptor {beta} Activates the Human Retinoic Acid Receptor {alpha}-1 Promoter in Response to Tamoxifen and Other Estrogen Receptor Antagonists, but Not in Response to Estrogen Mol. Endocrinol., March 1, 1999; 13(3): 418 - 430. [Abstract] [Full Text]

				G. A. Peters and S. A. Khan Estrogen Receptor Domains E and F: Role in Dimerization and Interaction with Coactivator RIP-140 Mol. Endocrinol., February 1, 1999; 13(2): 286 - 296. [Abstract] [Full Text]

				G. A. Stafford and R. H. Morse Mutations in the AF-2/Hormone-binding Domain of the Chimeric Activator GAL4·Estrogen Receptor·VP16 Inhibit Hormone-dependent Transcriptional Activation and Chromatin Remodeling in Yeast J. Biol. Chem., December 18, 1998; 273(51): 34240 - 34246. [Abstract] [Full Text] [PDF]

				E. M. McInerney, K. E. Weis, J. Sun, S. Mosselman, and B. S. Katzenellenbogen Transcription Activation by the Human Estrogen Receptor Subtype {beta} (ER{beta}) Studied with ER{beta} and ER{alpha} Receptor Chimeras Endocrinology, November 1, 1998; 139(11): 4513 - 4522. [Abstract] [Full Text] [PDF]

				M. Tsai-Pflugfelder, S. M. Gasser, and W. Wahli Functional Interaction between the Estrogen Receptor and CTF1: Analysis of the Vitellogenin Gene B1 Promoter in Yeast Mol. Endocrinol., October 1, 1998; 12(10): 1525 - 1541. [Abstract] [Full Text]

				J. D. Norris, D. Fan, M. R. Stallcup, and D. P. McDonnell Enhancement of Estrogen Receptor Transcriptional Activity by the Coactivator GRIP-1 Highlights the Role of Activation Function 2 in Determining Estrogen Receptor Pharmacology J. Biol. Chem., March 20, 1998; 273(12): 6679 - 6688. [Abstract] [Full Text] [PDF]

				W. Porter, B. Saville, D. Hoivik, and S. Safe Functional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor Mol. Endocrinol., October 1, 1997; 11(11): 1569 - 1580. [Abstract] [Full Text]

				J. R. Wilkinson and H. C. Towle Identification and Characterization of the AF-1 Transactivation Domain of Thyroid Hormone Receptor beta 1 J. Biol. Chem., September 19, 1997; 272(38): 23824 - 23832. [Abstract] [Full Text] [PDF]

				C. L. Smith, Z. Nawaz, and B. W. O’Malley Coactivator and Corepressor Regulation of the Agonist/Antagonist Activity of the Mixed Antiestrogen, 4-Hydroxytamoxifen Mol. Endocrinol., June 1, 1997; 11(6): 657 - 666. [Abstract] [Full Text]

				W. P. Bocchinfuso and K. S. Korach Estrogen Receptor Residues Required for Stereospecific Ligand Recognition and Activation Mol. Endocrinol., May 1, 1997; 11(5): 587 - 594. [Abstract] [Full Text]

				K. Ramamoorthy, F. Wang, I-C. Chen, J. D. Norris, D. P. McDonnell, L. S. Leonard, K. W. Gaido, W. P. Bocchinfuso, K. S. Korach, and S. Safe Estrogenic Activity of a Dieldrin/Toxaphene Mixture in the Mouse Uterus, MCF-7 Human Breast Cancer Cells, and Yeast-Based Estrogen Receptor Assays: No Apparent Synergism Endocrinology, April 1, 1997; 138(4): 1520 - 1527. [Abstract] [Full Text] [PDF]

				E. J. Routledge and J. P. Sumpter Structural Features of Alkylphenolic Chemicals Associated with Estrogenic Activity J. Biol. Chem., February 7, 1997; 272(6): 3280 - 3288. [Abstract] [Full Text] [PDF]

				A. Joyeux, V. Cavaillès, P. Balaguer, and J. C. Nicolas RIP 140 Enhances Nuclear Receptor-Dependent Transcription in Vivo in Yeast Mol. Endocrinol., February 1, 1997; 11(2): 193 - 202. [Abstract] [Full Text]

				E. M. McInerney and B. S. Katzenellenbogen Different Regions in Activation Function-1 of the Human Estrogen Receptor Required for Antiestrogen- and Estradiol-dependent Transcription Activation J. Biol. Chem., September 27, 1996; 271(39): 24172 - 24178. [Abstract] [Full Text] [PDF]

				H. Wang, G. A. Peters, X. Zeng, M. Tang, W. Ip, and S. A. Khan Yeast Two-hybrid System Demonstrates That Estrogen Receptor Dimerization Is Ligand-dependent in Vivo J. Biol. Chem., October 6, 1995; 270(40): 23322 - 23329. [Abstract] [Full Text] [PDF]

				D. Metzger, S. Ali, J.-M. Bornert, and P. Chambon Characterization of the Amino-terminal Transcriptional Activation Function of the Human Estrogen Receptor in Animal and Yeast Cells J. Biol. Chem., April 21, 1995; 270(16): 9535 - 9542. [Abstract] [Full Text] [PDF]

				I. Tcherepanova, P. Puigserver, J. D. Norris, B. M. Spiegelman, and D. P. McDonnell Modulation of Estrogen Receptor-alpha Transcriptional Activity by the Coactivator PGC-1 J. Biol. Chem., May 19, 2000; 275(21): 16302 - 16308. [Abstract] [Full Text] [PDF]

				R. V. Weatherman and T. S. Scanlan Unique Protein Determinants of the Subtype-selective Ligand Responses of the Estrogen Receptors (ERalpha and ERbeta ) at AP-1 Sites J. Biol. Chem., February 2, 2001; 276(6): 3827 - 3832. [Abstract] [Full Text] [PDF]